Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hehe Shuyangfang + Anluo Huaxian
- Development stage
- Unknown
- Lead developer
- Beijing Hospital of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Hehe Shuyangfang + Anluo Huaxian is a combination of two traditional Chinese medicine (TCM) formulations. While detailed information on "Hehe Shuyangfang" is limited in the provided sources and broader literature, "Anluo Huaxian" (also known as An-Luo-Hua-Xian Pill or Wan) is a well-studied TCM product used primarily for the treatment of liver fibrosis and chronic hepatitis B. Anluo Huaxian contains multiple herbal ingredients and exerts its effects by inhibiting hepatic stellate cell activation, reducing oxidative stress and apoptosis in liver cells, regulating extracellular matrix metabolism and angiogenesis in the liver, as well as modulating inflammatory cytokines. Clinical studies have shown that when combined with standard antiviral therapies such as entecavir or tenofovir, it can significantly improve regression rates of liver fibrosis in patients with chronic hepatitis B or cirrhosis[1][2][3][4]. The mechanism involves anti-fibrotic activity through modulation of molecular pathways related to inflammation and fibrogenesis.
- Other names
- Hehe ShuyangfangAnluo HuaxianAn-Luo-Hua-Xian PillAnluo HuaXian Wan
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))PI3K (Phosphoinositide-3-kinase regulatory subunit 6)
Beyond the preview
Go deeper on Hehe Shuyangfang + Anluo Huaxian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hehe Shuyangfang + Anluo Huaxian.